XML 68 R30.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Investments (Tables)
6 Months Ended
Jun. 29, 2024
Investments, Debt and Equity Securities [Abstract]  
Investments Classified by Contractual Maturity Date [Table Text Block]
The fair value of marketable debt investments, by contractual maturity, as of June 29, 2024, was as follows:
(In Millions)Fair Value
Due in 1 year or less
$11,498 
Due in 1–2 years
1,987 
Due in 2–5 years
6,141 
Due after 5 years
241 
Instruments not due at a single maturity date1
5,396 
Total$25,263 
1 Instruments not due at a single maturity date is comprised of money market fund deposits, which are classified as either short-term investments or cash and cash equivalents.
Investment [Table Text Block]
(In Millions)Jun 29, 2024Dec 30, 2023
Marketable equity securities1
$1,246 $1,194 
Non-marketable equity securities
4,574 4,630 
Equity method investments
Total$5,824 $5,829 
1    Substantially all of our marketable equity securities are subject to trading-volume or market-based restrictions, which limit the number of shares we may sell in a specified period of time, impacting our ability to liquidate these investments. Certain of the trading volume restrictions generally apply for as long as we own more than 1% of the outstanding shares. Market-based restrictions result from the rules of the respective exchange.
Gain (Loss) on Securities [Table Text Block]
The components of gains (losses) on equity investments, net for each period were as follows:
 Three Months EndedSix Months Ended
(In Millions)
Jun 29, 2024Jul 1, 2023Jun 29, 2024Jul 1, 2023
Ongoing mark-to-market adjustments on marketable equity securities
$(43)$(85)$(134)$103 
Observable price adjustments on non-marketable equity securities
25 — 49 10 
Impairment charges
(91)(38)(159)(74)
Sale of equity investments and other1
(11)99 329 106 
Total gains (losses) on equity investments, net$(120)$(24)$85 $145 
1 Sale of equity investments and other includes initial fair value adjustments recorded upon a security becoming marketable, realized gains (losses) on sales of non-marketable equity investments and equity method investments, and our share of equity method investee gains (losses) and distributions.